Funding Opportunities and Announcements

HRSA Announces FY 2022 Ending the HIV Epidemic - Primary Care HIV Prevention (PCHP) Competitive Funding Opportunity for Health Centers

Notice of Intent to Publish a Funding Opportunity Announcement for Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN) Scientific Leadership Center (UM2 Clinical Trial Required), and Operations and Collaborations Center (UM1 Clinical Trial)

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) (K99/R00 and UE5)

Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)

Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)

NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)  

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities), standard AIDS dates apply. Expires in 2023:

• R21 Clinical Trial Optional
• R01 Clinical Trial Optional

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)